DoH Abu Dhabi
-
DoH Abu Dhabi partners with Pfizer Gulf to advance healthcare research with Real World Data Workshop
The workshop brought together over 60 participants, including researchers, data scientists, pharmacists, and healthcare professionals from leading hospitals and academic institutions across Abu Dhabi.
-
Abu Dhabi launches HELM cluster to become global biotech and health hub
HELM cluster’s mission is to accelerate the creation and deployment of advanced health and life science solutions, ranging from AI-powered diagnostics and pharmaceutical manufacturing to gene therapies and precision medicine.
-
Abu Dhabi, ADIO, and Masdar City to establish advanced research labs
Under the agreement, the initiative will focus on four main pillars. First, it will develop state-of-the-art laboratory infrastructure in Masdar City, equipped with the latest technologies to support advanced scientific research.
-
Abu Dhabi’s M42 invests in UK Longevity biotech Juvenescence
M42 and Juvenescence will work together to identify and develop a pipeline of AI-enabled therapeutics to extend healthy human lifespan and improve treatments for life-threatening and chronic diseases.
-
PureHealth, Khalifa University, Illumina, M42, IHLAD, and NYUAD partner with DoH for precision medicine advancement
This agreement aligns with DoH’s vision to create an intelligent healthcare system powered by genomic science, AI insights, and innovation across critical areas such as oncology, rare genetic diseases, and metabolic disorders.
-
DoH Abu Dhabi, ADIO partner with GSK to establish multi-omics research institute
The institute aims to provide deeper insights into biological processes and improve cancer patient outcomes by focusing on multi-omics, integrating data from genes, RNA, proteins, and metabolites.